hepatology
FDA Approves Seladelpar for Primary Biliary Cholangitis
The FDA has granted accelerated approval to Livdelzi in combination with ursodeoxycholic acid for adults with PBC.
AUGUST 23, 2024
ACG Issues Updated Guidance on Alcohol-Associated Liver Disease
The American College of Gastroenterology recently published a guideline on alcohol-associated liver disease.
AUGUST 15, 2024
FDA Approves Maralixibat for Cholestatic Pruritus in PFIC
The FDA approved Livmarli for cholestatic pruritus in patients 5+ years with PFIC.
MARCH 17, 2024
FDA Approves Resmetirom, First Drug for MASH
The FDA granted accelerated approval to the first medication for the treatment of MASH, Rezdiffra.
MARCH 16, 2024
How to Treat Liver Disease In the Midst of Health Disparities
Liver disease is on the rise in the United States, but not everyone has equal access to care.
FEBRUARY 26, 2024
Aldafermin Shown to Reduce ELF Scores in Patients With MASH Cirrhosis
A trial evaluating aldafermin has found it effective and largely well tolerated in patients with compensated ...
FEBRUARY 20, 2024
Nearly One-Fifth of Cirrhosis Patients Prescribed Opioids at Outpatient Visits
Almost one in five outpatient clinic visits by patients with cirrhosis involve an opioid prescription, according to ...
MARCH 10, 2022
